MktsMarkets

Immuneering Corporation
NASDAQ: IMRXKey statistics
IMRX News
Stories mentioning IMRX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 10,645 | 9,254 | 10,868 | 10,454 | 11,472 | 14,857 | 11,253 | 10,652 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 15,335 | 13,752 | 15,381 | 14,758 | 15,485 | 18,557 | 15,274 | 14,914 |
| Operating Income (Loss) | (15,335) | (13,752) | (15,381) | (14,758) | (15,485) | (18,557) | (15,274) | (14,914) |
| Interest Income | 1,360 | 1,860 | 416.00 | 324.00 | 439.00 | 415.00 | 547.00 | 826.00 |
| Interest Expense | ||||||||
| Other Expense | 514.00 | 312.00 | 0.00 | 0.00 | 0.00 | 91.00 | 129.00 | 8.00 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (13,461) | (11,580) | (14,965) | (14,434) | (15,046) | (18,052) | (14,597) | (14,080) |
| Earnings Per Share (Basic) | (0.21) | (0.26) | (0.38) | (0.40) | (0.42) | (0.60) | (0.49) | (0.47) |
| Earnings Per Share (Diluted) | (0.21) | (0.26) | (0.38) | (0.40) | (0.42) | (0.60) | (0.49) | (0.47) |
| Weighted Average Shares Outstanding (Basic) | 64,659 | 44,012 | 39,670 | 35,986 | 35,530 | 29,982 | 29,842 | 29,653 |
| Weighted Average Shares Outstanding (Diluted) | 64,659 | 44,012 | 39,670 | 35,986 | 35,530 | 29,982 | 29,842 | 29,653 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About IMRX
Immuneering Corporation (NASDAQ: IMRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol IMRX. It last traded at $3.46 (Nov 17, 2026, 4:00 PM ET), down 1.7% on the day. That gives Immuneering a market capitalisation of $228.0M.
Over the past 52 weeks IMRX has traded between $3.35 and $8.48.
For the quarter ended Mar 31, 2026 it reported a net loss of $13.5M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$13.5M |
| Dec 31, 2025 | — | -$11.6M |
| Sep 30, 2025 | — | -$15.0M |
| Jun 30, 2025 | — | -$14.4M |
From Immuneering’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…